Technical Analysis for MRVI - Maravai LifeSciences Holdings, Inc.

Grade Last Price % Change Price Change
grade F 29.16 8.16% 2.20
MRVI closed up 8.16 percent on Friday, November 27, 2020, on 1.45 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical MRVI trend table...

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Hot IPO Pullback Bullish Swing Setup 8.16%
Inside Day Range Contraction 8.16%
New 52 Week Closing Low Bearish 10.92%
Hot IPO Pullback Bullish Swing Setup 10.92%
New 52 Week Low Weakness 10.92%
Older End-of-Day Signals for MRVI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Maravai LifeSciences Holdings, Inc. operates as a life sciences company that provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in three segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry. The company serves biopharmaceutical companies, and other emerging biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.
Biotechnology Biopharmaceutical Life Sciences Biology Gene Therapy Antibody Molecular Diagnostics Human Diseases Biopharmaceutical Products In Vitro Diagnostics Chemical Synthesis Drug Therapies Analytical Products Assay Development Services

Is MRVI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 32.46
52 Week Low 25.56
Average Volume 3,561,254
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 0.00
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Fundamentals Value
Market Cap 2.82 Billion
Num Shares 96.6 Million
EPS
Price-to-Sales 31.33
Price-to-Book 65.57
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.45
Resistance 3 (R3) 33.34 31.81 32.73
Resistance 2 (R2) 31.81 30.71 31.86 32.50
Resistance 1 (R1) 30.48 30.04 31.14 30.59 32.26
Pivot Point 28.95 28.95 29.28 29.00 28.95
Support 1 (S1) 27.62 27.85 28.29 27.73 26.06
Support 2 (S2) 26.09 27.18 26.14 25.82
Support 3 (S3) 24.76 26.09 25.59
Support 4 (S4) 24.87